Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 3, 2005
app pub date -
Dec 9, 2004
filing date -
Dec 9, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The disclosed invention is a composition for and a method of treating a HIV infection in a host, such as a human, using a single, once a day, oral dose of .beta.-D-D4FC in an enteric-coated tablet. The enterically coated .beta.-D-D4FC increases the amount of the drug that remains in active form for use in inhibiting the HIV virus in vivo.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully